expression of complement components and complement regulatory proteins by keratinocytes. In vivo, UVB may up-regulate these proteins by direct effects or via cytokines released by keratinocytes or infiltrating inflammatory cells. In vitro, UVB may up-regulate these proteins only directly, because of dilution of released cytokines in the medium. To test this, we exposed cultured human keratinocytes to UVB (0-64 J per m 2 ) and monitored C3 and factor B release in the medium by enzyme-linked immunosorbent assay, and surface expression of membrane cofactor protein, decay accelerating factor, and CD59 by flow cytometry. Keratinocytes produced small amounts of C3 and factor B, which remained unaffected by UVB. UVB (32 J per m 2 )
caused a transient up-regulation of all three complement regulatory proteins. Decay accelerating factor expression was maximal at 48 h (1.81 ± 0.06-fold increase in mean fluorescence intensity over non exposed cells), membrane cofactor protein at 72 h (2.13 ± 0.09-fold increase in mean fluorescence intensity), and CD59 at 120 h (1.96 ± 0.09-fold increase in mean fluorescence intensity), returning to baseline values within 96, 192 and 192 h, respectively . Exposure to 64 J per m 2 resulted in significant cell death; cells surviving this dose up to 48 h expressed a higher level of all the three proteins than those surviving 32 J per m 2 .
In conclusion, UVB up-regulated membrane cofactor protein, decay accelerating factor, and CD59 on keratinocytes without affecting the constitutive release of C3 and factor B. Thus, UVB can increase the resistance of keratinocytes against their own complement known to be produced excessively in response to cytokines of inflammatory cells which infiltrate the skin following UVB exposure. and factor B and, (2) the surface expression of DAF, MCP and CD59.
MATERIALS AND METHODS
Keratinocyte culture Human keratinocytes were isolated by incubation of foreskin with thermolysin (0.50 mg per ml, Sigma, St. Louis, Mo) at 4°C for 16 h and subsequent trypsinization (0.025%) for 5 min at 37°C. Trypsin (Sigma) was then neutralized by an excess volume of heat inactivated fetal calf serum (GibcoBRL, Breda, The Netherlands). Cells were separated from debris by filtering through a nylon mesh, centrifuged, and resuspended in keratinocyte serum free medium (GibcoBRL) supplemented with penicillin/streptomycin (100 IU per ml, 100 ug per ml; GibcoBRL). The keratinocytes were plated onto 100 mm plastic Petri dishes at a density of 400,000 cells per Petri dish and were incubated at 37°C in humidified. 5% C0 2 , tissue culture incubator. Medium was changed every 2-3 d, and at 70% confluence cultures were split after a 5 min exposure to trypsin (0.025%)/ethylenediamine telraacetic acid (EDTA) (1.5 mM) and recultured. For use in experiments, cells were seeded in 6 well tissue culture plates (Costar) at a density of 100,000 cells per well in 2000 ul of medium. Cells in passage 2-5 were used for experiments as soon as 60-80% confluence was achieved. Cells in representative wells were counted by a hemacytometer before the experiment and cells in all wells were counted after finishing the experiment.
UV exposure and cell viability
Subconfluent cultures (60-80%) of keratinocytes in 6 well culture plates were washed twice with phosphate-buffered saline (PBS), exposed to increasing doses of UVB (0-64 J per m 2 ), brought to 2 ml of culture medium and cultured for 48 or 72 h in two sets of experiments. After incubation, keratinocytes were counted with a hemacytometer and after propidium iodide staining viability of these cells was determined by flow cytometer. Cell survival after UVB exposure was expressed as the percentage of control nonexposed alive cells. Doses that were not lethal to the majority of the exposed keratinocytes at a given time after exposure (48 or 72 h) were used in subsequent experiments.
The UVB source consisted of a bank of two Philips TL-12 lamps (Philips, Eindhoven, The Netherlands).
These lamps emit UV in the range of 250-400 nm, primarily in the UVB region (280-320 nm), with a peak at 315 nm. The UVB output was 1 J per m 2 per second at a target distance of 40 cm and was monitored by an IL443 radiometer with a SEE 1240 UVB photo detector (International Light Inc., Newburyport, MA, USA).
Enzyme-linked immunosorbent assay (ELISA) for measurement of C3, factor B, and IL-8
The concentrations of C3, factor B, and IL-8 in culture supernatants of UVB exposed and non-exposed keratinocytes were estimated as follows.
For quantification of C3 a previously described sandwich ELISA 261 was used with some modifications.
Briefly, wells of 96-well flat-bottom microliter plates were coated with 0.7 ug polyclonal goat IgG anti-human C3 (Cappel, Boxtel, The Netherlands) per ml in 100 pi carbonate buffer (pH 9.6) overnight at 4°C. After thorough washing with Tween-80 (0.05%) (Sigma) in demineralized water the wells were blocked for 1 h at room temperature with 250 pi PBS containing 2% bovine serum albumin (Sigma) and 1 mM EDTA. Washing was repeated and wells were incubated with 100 pi of sample, diluted in the same buffer that was used for blocking. Plates were incubated for 2 h at 37°C. The wells were then washed and incubated with 100 u 1 peroxidase labeled goat anti-human C3 IgG (0.05 pg per ml) (Cappel) for 1 h at 37°C. After washing the wells were incubated with 100 pi 3,3',5,5'tetramethylbenzidine (Sigma) in dimethylsulfoxide (Merck, Hohenbrunn, Germany)-citrate buffer for 10 min. Reaction was stopped with 100 u 1 H 2 S0 4 (2 M). Optical density (OD) was measured at 450 nm. The detection limit of this ELISA was 1 ng per ml of C3.
Factor B was assayed by a previously described sandwich ELISA 262 with several modifications. Briefly, wells were coated overnight at 4°C with 3 pg polyclonal goat-anti-human factor B IgG (ATAB, Stillwater, MN, USA) per ml in carbonate buffer. After thorough washing with PBS/Tween-80 (0.05%), wells were blocked with PBS/mi Ik powder (2%) (Nutricia, Zoetermeer, The Netherlands) for 1 h at room temperature, and then washed again. Wells were then incubated for 2 h at 37°C with 100 pi sample, diluted in same buffer that was used for blocking, and washed. They were then incubated with biotinylated goat anti-human factor B IgG (1.25 pg per ml) for 1 h at 37°C. After washing, the wells were incubated for another h at 37°C with peroxidase conjugated poly streptavidin (1:1000; DAKO. Glostrup, Denmark). The wells were then repeatedly washed. Incubation of the wells with the peroxidase substrate, termination of the reaction, and measurement of OD was carried out as described for C3. The detection limit of this ELISA was 100 pg per ml.
For IL-8 ELISA, wells were coated with 1 p g monoclonal mouse-anti-human IL-8 (Biosource, Breda, The Netherlands) per ml in 100 pi carbonate buffer (pH 9.6) overnight at 4°C. After thorough washing with Tween-80 (0.05%) in PBS the wells were blocked for 1 h at 37°C with 200 pi of PBS containing 1% bovine serum albumin. Washing was repeated and wells were incubated with 100 pi of sample, diluted in the same buffer that was used for blocking. Plates were incubated for 2 h at 37°C. The wells were then washed and incubated with 100 pi biotinylated mouse anti-human IL-8 (0.1 pg per ml) (Biosource) for 1 h at 37°C. After washing, the wells were incubated for another h at 37 °C with peroxidase conjugated poly streptavidin (1:1000; DAKO) in PBS/Tween (0.05%)/milkpowder (1 %). The wells were then repeatedly washed. Incubation of the wells with the peroxidase substrate, termination of the reaction, and measurement of OD was carried out as described for C3. The detection limit of this ELISA was 5 pg per ml.
Standard curves for C3 and factor B ELISA were made using human complement calibrator CA1 (ATAB). Standard curve for IL-8 ELISA was made using IL-8 Calibrator (Biosource).
Flow cytometry
Keratinocytes were detached with the trypsin/EDTA solution for 3-5 min. The detachment of keratinocytes with trypsin (0.025%)/EDTA (1.5 mM) at 37°C for 3-5 min did not cause degradation of any of the three complement regulatory proteins, as expression of these molecules on cells detached by this procedure was the same as on those detached with EDTA (2 mM) alone at 42 °C for 30 min. The former procedure was selected because it did not cause loss of cell viability, whereas latter procedure caused a high degree of loss of cell viability.
Mean fluorescence intensity (MFI) was calculated with WinMDI software. MFI was corrected for isotype MFI and values of cells not exposed to UVB were taken as 100%. MFI values obtained from cells exposed to UVB were presented in terms of percent of nonexposed cells.
Statistical analysis
Statistical analysis was performed using Wilcoxon signed rank test to determine significance in FACS experiments and a Student / test was used for data from EL1SA experiments. A p value of less than 0.05 was considered significant.
RESULTS

Increasing doses of UVB cause progressive loss of cell viability
In order to study the effect of UVB exposure on the expression of complement and complement regulatory proteins by keratinocytes, suitable doses of UVB were determined as 
UVB exposure has no influence on the synthesis of C3 and factor B by keratinocytes
To see if UVB influences the constitutive production of C3 and factor B, keratinocytes were exposed to increasing doses of UVB (4-32 J per m 2 ). Non-exposed cells served as controls.
Both exposed and nonexposed cells were cultured for 72 h and supernatants were collected. The concentrations of C3, factor B, and IL-8 were measured by ELISA in the supernatants.
In supernatants harvested from cultures of nonexposed keratinocytes C3, factor B, and IL-8 were found to be present in low concentrations. In supernatants of cultures of keratinocytes exposed to increasing doses of UVB, concentrations of C3 and factor B remained low but the concentration of IL-8 was significantly increased (Figure 2 ). IL-8 production was highest at 32 J per m 2 . The maximal IL-8 level in the supernatant was 609 pg per ml. To exert biological activity much higher concentrations are required 309 . These results show that UVB activates keratinocytes, as could be concluded from the IL-8 production, but does not directly increase the production of C3 and factor B.
Cultured keratinocytes express DAF, MCP and CD59
Previous immunohistochemical studies in our laboratory have shown that DAF, MCP and CD59 were present in situ on several structures of human skin, including keratinocytes".
Flow cytometric analysis of cultured keratinocytes in this study confirmed that all three proteins were expressed on these cells (Figure 3) . 
Increasing doses of UVB cause a dose-dependent increase in surface expression of complement regulatory proteins
Time-response studies described above showed that with 32 J per m 2 surface expression of DAF was maximal at 48 h of culture after irradiation and surface expression of MCP and CD59 was maximal at 72 h. Therefore, dose-response studies with a moderate dose of up to 32 J per m 2 were carried out at 48 h of culture after irradiation for DAF and at 72 h of culture after irradiation for MCP and CD59. In the case of the expression of DAF, there was no effect of UVB doses up to 16 J per m 2 but the expression was significantly increased with 32 J per m 2 (Table) .
In the case of MCP and CD59, expression gradually increased from 8 J per m 2 onwards and reached its maximum at 32 J per m 2 .
A high dose of UVB results in a high surface expression of DAF, MCP and CD59
Further studies were aimed at comparing the effects of moderate (32 J per m 2 ) and high dose of UVB (64 J per m 2 ) on the expression of all the three complement regulatory proteins. These studies were carried out at 48 h of culture because of the low degree of cell survival at 72
h of cells exposed to 64 J per m 2 (see above). The results showed that expression of all the three complement regulatory proteins was higher with 64 J per m 2 than with 32 J per m 2 , although the difference in expression of MCP did not reach significant levels (p=0.18) (Figure 5 ).
DISCUSSION
UVB radiation is the mid range portion (290-320 nm) of the ultraviolet radiation spectrum (200-400 nm). UVB is present in biologically significant amounts at the earth's surface and exhibits pleomorphic effects both on the whole organism and on the skin. It penetrates the stratum basale and reaches the keratinocytes. UVB increases production of several cytokines by keratinocytes. Some of these cytokines recruit inflammatory cells and thereby induce inflammation at the site of UVB exposure of the skin 303;219;304 . Alteration in production of some cytokines by UVB induces immunosuppression 307 .
In many inflammatory disorders, like psoriasis, atopic dermatitis, seborrhoeic dermatitis, and lamellar ichthyosis, complement deposits are found in the epidermis without the presence of autoantibodies 310 . In some autoimmune diseases, such as pemphigus, pemphigoid, discoid lupus erythematosus, and photosensitive lupus erythematosus, complement deposits on keratinocytes are seen in lesional skin but can also be induced in nonlesional skin by UVB exposure 311312 . In some diseases of unknown etiology such as photoallergy, polymorphous light eruptions, solar urticaria, solar eczema, and actinic reticuloid, the disease is exacerbated by light but the role of complement remains unknown. In none of these diseases is the origin of complement in the skin known. And, in none of these diseases, except aforementioned autoimmune diseases, has the effect of UVB on the development of complement deposits been studied. In spite of these gaps in knowledge, studies on the effects of UV exposure on the expression of complement and complement regulatory proteins by keratinocytes isolated from normal individuals and from patients has not been carried out.
We argued that UVB exposure can probably increase the constitutive production of complement components by keratinocytes. In evolutionary terms, this may be to compensate for local immunosuppression induced by UVB. We also argued that UVB exposure can increase the surface expression of complement regulatory proteins on keratinocytes to protect them from their own complement. We raised the possibility that UVB can up-regulate the synthesis of both complement and complement regulatory proteins, either directly or indirectly via cytokines released by keratinocytes or infiltrated inflammatory cells.
We observed that keratinocytes constitutively produced small amounts of C3 and factor B. This was in agreement with previous observations 34, 35 . Exposure to UVB caused stimulation of keratinocytes, as evidenced by the production of IL-8, but did not increase production of C3 and factor B ( Figure 2 ). This proved that direct stimulation of keratinocytes by UVB could not induce an increase in production of C3 and factor B. This also raised the question why those C3
and factor B up-regulating cytokines that are released from keratinocytes upon UVB exposure do not increase the production of C3 and factor B in our system. One of the possible explanations is that they may be released in the medium in concentrations not high enough to stimulate the keratinocytes. The concentrations of TNF-a needed to up-regulate C3 in our system were 50-1000 U per ml. But the concentrations of TNF-a in culture medium of UVB exposed keratinocytes (at 72 h) was found to be very low (< 1 U per ml; data not shown here). The same appears to be true for IL-8, whose effects on the expression of C3, factor B, and complement regulatory proteins is not known. The level of IL-8 in the culture medium of UVB exposed keratinocytes was always lower than 610 pg per ml (Figure 2 The increased expression of DAF, MCP and CD59 seen in vitro could have been due either to a direct effect of UVB on keratinocytes or an indirect effect in response to mediators released by keratinocytes. The latter possibility appears to be less likely because the concentrations of cytokines released from UVB-exposed keratinocytes into the culture medium do not appear to be high enough to be able to up-regulate complement regulatory proteins significantly.
If these findings may be extrapolated to the in vivo situation, keratinocytes in UVB exposed areas may be better protected against complement mediated lysis than keratinocytes in nonexposed areas. The situation in vitro, however, may differ from the situation in vivo in which infiltrating cells may also influence the expression of complement regulatory proteins through the release of their cytokines.
UVB is known to activate protein kinase complement in keratinocytes 314 . Increase in expression of DAF, MCP and CD59 by activators of protein kinase C, phorbol myristate acetate, and calcium ionophore A23187, and an activator of protein kinase A, butyryl-cAMP, has been shown in our laboratory (data not presented here). Protein kinase complement and protein kinase A signalling may perhaps be involved in the up-regulation of DAF, MCP and CD59 by UVB.
In conclusion, this study demonstrates that cultured human keratinocytes constitutively release low amounts of C3 and factor B, which remains unaffected by UVB. They also express DAF, MCP and CD59. Expression of these complement regulatory proteins is increased by UVB.
Because UVB may increase complement production in vivo through cytokines of keratinocytes and infiltrated cells, this increase in complement regulatory proteins may be important for protecting keratinocytes from becoming bystander victims of complement during UVB-mediated inflammation.
